| ISIN | LU1585228379 |
|---|---|
| Valorennummer | |
| Bloomberg Global ID | |
| Fondsname | Bellevue Emerging Markets Healthcare I2 |
| Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fondsanbieter | Bellevue Asset Management AG |
| Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
| Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
| Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
| Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
| Besonderheiten |
| Aktueller Preis * | 143.95 USD | 08.01.2026 |
|---|---|---|
| Vorheriger Preis * | 143.99 USD | 07.01.2026 |
| 52 Wochen Hoch * | 150.11 USD | 08.10.2025 |
| 52 Wochen Tief * | 108.93 USD | 09.04.2025 |
| NAV * | 143.95 USD | 08.01.2026 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 52'205'785 | |
| Anteilsklassevermögen *** | ||
| Trading Information SIX | ||
| YTD-Performance | +7.19% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| YTD-Performance (in CHF) | +7.96% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
| 1 Monat | +3.43% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 Monate | -4.10% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 Monate | +9.00% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 Jahr | +25.91% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 Jahre | +10.36% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 Jahre | -7.10% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 Jahre | -42.35% |
15.06.2021 - 08.01.2026
15.06.2021 08.01.2026 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BeOne Medicines Ltd Ordinary Shares | 7.03% | |
|---|---|---|
| Celltrion Inc | 6.77% | |
| Sun Pharmaceuticals Industries Ltd | 6.62% | |
| Innovent Biologics Inc | 6.20% | |
| Samsung BioLogics Co Ltd | 4.91% | |
| WuXi Biologics (Cayman) Inc | 4.66% | |
| Akeso Inc Ordinary Shares | 3.79% | |
| Sino Biopharmaceutical Ltd | 3.54% | |
| Max Healthcare Institute Ltd Ordinary Shares | 3.07% | |
| Hansoh Pharmaceutical Group Co Ltd | 3.03% | |
| Letzte Daten-Aktualisierung | 30.11.2025 | |
| TER | 1.51% |
|---|---|
| Datum TER | 29.01.2021 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.90% |
| Ongoing Charges *** | 1.33% |
|
SRRI ***
|
|
| Datum SRRI *** | 31.12.2025 |